Claudia's knowledge is deeply rooted in medical and nutritional science as well as cutting edge pharmacology and drug discovery, which puts her into a class of her own. Her immense knowledge of natural precursors (medicinal plant science) to conventional drugs and the effects on those on the human body allows her, in her capacity as a phytomedical practitioner (practitioner of plant based medicine), to dispense and prescribe customised phytomedcines to her patients if required and appropriate.

 

As a conventional pharmacologist she is also able to advise patients of potential interactions between plant based and allopathic medicines and on the side-effect of conventional medicines alone, which makes Claudia a unique practitioner in her field, who is able to cross over and bring together the boundaries of natural and conventional medication to the benefit of her patients.

 

Years of scientific laboratory practice in academia and medical research, as well a years of experience in clinical practice and diagnostic skills, are reflected in her cutting edge practice and make her a leading practitioner of nutritional and phytomedical science.

 

Claudia uses the latest diagnostic tools and laboratory tests to understand fully the health status of each patient prior customising a diet and uses the same tools to monitor and support each patient throughout the diet. Claudia is very happy and accustomed to communicate with the patients' GP or health-specialist if this is required.

 

Claudia's scientific expertise is much in demand as the many articles in national daily newspapers and magazines can testify in the PR section on our website. Claudia featured also as the chosen nutritionist on the BBC programme the 'Supersizers'.

 

Claudia's interest lies in malnutrition, that is over-nutrition and under-nutrition, which accounts for excess health costs of £10 billion each year in the United Kingdom. Obesity is clearly a “headline” item because of its visible prevalence and personal, clinical and societal costs, especially amongst younger people. In Europe and in the United States, nearly two thirds of men are either overweight or clinically obese and this contributes one-fifth to one-quarter of the risk of stroke, hypertension, heart attack and diabetes, in addition to the emerging risk of  non-alcoholic fatty liver disease.